An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system

Journal of Hypertension

Volumn 15, Issue 1, 1997, Pages 65-72

  Komiya, Ichiro ^d   Yamada, Takashi ^a   Takasu, Nobuyuki ^d   Asawa, Takayuki ^d   Akamine, Hiromitsu ^d   Yagi, Noriharu ^d   Nagasawa, Yoshitaka ^d   Ohtsuka, Hiromi ^a   Miyahara, Yasuhiro ^a   Sakai, Hideki ^a   Sato, Akira ^b   Aizawa, Toru ^c  

^a Kashiwa Municipal Hospital   (Japan)

^b DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

Author keywords

Essential hypertension; Renin aldosterone system; Serum sodium concentration

Indexed keywords

ALDOSTERONE; RENIN; SODIUM;

ADENOMA; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HORMONE RELEASE; HUMAN; HYPERALDOSTERONISM; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SODIUM BLOOD LEVEL; SODIUM INTAKE; SODIUM METABOLISM; SODIUM URINE LEVEL;

EID: 8044252797     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715010-00006     Document Type: Article

References (35)

1. Haddy FJ: Mechanism, prevention and therapy of sodium-dependent hypertension. Am J Med 1980, 69:746-758.
2. Coleman TG, Manning RD Jr, Norman RA Jr, Granger HJ, Guyton AC: The role of salt in experimental and human hypertension. Am J Med Sci 1972, 264:103-110.
3. Shimamoto H, Shimamoto Y: Time course of hemodynamic responses to sodium in elderly hypertensive patients. Hypertension 1990, 16:387-397.
4. Conway J, Lauwers P: Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation 1960, 21:21-27.
5. Wilson IM, Freis ED: Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation 1959, 20:1028-1036.
6. Meneely GR, Battarbee HD: High sodium-low potassium environment and hypertension. Am J Med 1976, 38:768-785.
7. Coleman TG, Norman RA Jr, Young DB: Mechanism of essential hypertension. In Arterial Pressure and Hypertension. Edited by Guyton AC. Philadelphia: W.B. Saunders; 1980:457-469.
8. Guyton AC, Coleman TG, Cowley AW Jr, Sheel KW, Manning RD Jr, Norman RA Jr: Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972, 52:584-594.
9. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW: Abnormal pressure natriuresis. A cause or a consequence of hypertension? Hypertension 1990, 15:547-559.
10. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, et al.: A screening test to identify aldosterone producing adenoma by measuring plasma renin activity, results in hypertensive patients. Arch Intern Med 1981, 141:1589-1593.
11. Komiya I, Yamada T, Takasu N, Aizawa T, Niwa A, Maruyama Y, et al.: Inappropriate elevation of the aldosterone/plasma renin ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone, a subtype of essential hypertension? Cardiology 1991, 78:99-110.
12. Komiya I, Takasu N, Ohara N, Nagasawa Y, Asawa T, Yamada T, et al.: Analysis of adrenocortical hyperplasia by computed tomography in patients with Cushing's disease, idiopathic hyperaldosteronism and adrenogenital syndrome. Endocrinol J 1994, 41:145-153.
13. Kesteloot H, Geboers J: Calcium and blood pressure. Lancet 1982, 1:813-815.
14. Aizawa T, Hiramatsu K, Ootsuka H, Kobayashi M, Koizumi Y, Yamada T, et al.: An elevation of BUN/creatinine ratio in patients with hyperthyroidism. Horm Metab Res 1986, 18:771-774.
15. Drayer JIM, Weber MA, Sealey JE, Laragh JH: Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics. Am J Med Sci 1981, 281:135-142.
16. Guyton AC: Blood pressure control - special role of the kidneys and body fluids. Science 1991, 252:1813-1816.
17. Williams GH: Essential hypertension as an endocrine disease. Endocrinol Metab Clin North Am 1994, 23:429-444.
18. Bühler FR, Laragh JH, Sealey JE, Brunner HR: Plasma aldosterone-renin interrelationships in various forms of essential hypertension. Am J Cardiol 1973, 32:554-561.
19. Lins PE, Adamson U: Plasma aldosterone-plasma renin activity ratio. A simple test to identify patients with primary aldosteronism. Acta Endocrinol 1986, 113:564-569.
20. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC: High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21:315-318.
21. McKenna TJ, Sequeira SJ, Heffernan A Chambers J, Cunningham S: Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991, 73:952-957.
22. Tuck ML, Dluhy RG, Williams GH: A specific role of saline or the sodium ion in the regulation of renin and aldosterone secretion. J Clin Invest 1974, 53:988-995.
23. Dahl LK: Salt intake and salt need. N Engl J Med 1958, 258:1152-1157.
24. Luetscher JA, Weinberger MH, Dowdy M, Nokes GW, Balikian H, Brodie A, et al.: Effects of sodium loading, sodium depletion and posture on plasma aldosterone concentration and renin activity in hypertensive patients. J Clin Endocrinol 1969, 29:1310-1318.
25. Collins RD, Weinberger MH, Dowdy AJ, Nokes GW, Gonzales CM, Luetscher JA: Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. J Clin Invest 1970, 49:1415-1426.
26. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Litton RP, Williams CS, Charru A, et al.: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-180.
27. Swales JD: Low-renin hypertension: nephrosclerosis? Lancet 1975, 1:75-77.
28. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure: less of one, more of other? Am J Hypertens 1988, 1:335-347.
29. Vargas F, Casanova I, Haro JM, Luna JD, Garcia del Rio C: Urinary excretion of digoxin-like factor (DLF) and ADH during DOCA-salt and Goldblatt 2 kidney-1 clip hypertension. Horm Metab Res 1990, 22:352-355.
30. Manning RD Jr, Guyton AC, Coleman TG, McCaa RE: Hypertension in dogs during antidiuretic hormone and hypotonic saline infusion. Am J Physiol 1979, 236:H314-H322.
31. Padfield PL, Brown JJ, Lever AF, Morton JJ, Robertson JI: Blood pressure in acute and chronic vasopressin excess: studies of malignant hypertension and syndrome inappropriate antidiuretic hormone secretion. N Engl J Med 1981, 304:1067-1070.
32. Morton JJ, Padfield PL: Vasopressin and hypertension in man. J Cardiovasc Pharmacol 1986, 8:5101-5106.
33. Kaysen GA, Myers BD: The aging kidney. Clin Geriatr Med 1985, 1:207-222.
34. Morris BJ: Identification of essential hypertension genes. J Hypertens 1993, 11:115-110.
35. Fardella CE, Rodriguez H, Hum DW, Mellon SH, Miller WL: Artificial mutations in p450c1 1 AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension? J Clin Endocrinol Metab 1995, 80:1040-1043.